AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
XYLOMETAZOLINE HCL
8 registrations across 4 African markets— 4 active
Markets with XYLOMETAZOLINE HCL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OTRIVIN ADULT NASAL SPRAY Nasal Spray | 🇰🇪Kenya | GlaxoSmithKline Limited | active | Oct 2030 |
| Decon pediatric nasal drops Nasal drops | 🇿🇲Zambia | Cadila Pharmaceuticals Limited | active | May 2029 |
| OTRINAL 0.1%W/V SOLUTION(NASAL SPRAY) SOLUTION(NASAL SPRAY) | 🇲🇼Malawi | — | expired | Mar 2025 |
| SINUTAB_ADULT_NASAL_SPRAY 1MG/ML SOLUTION SOLUTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| IVYNOZVIN_P_NASAL 0.05%W/V DROPS DROPS | 🇲🇼Malawi | — | expired | Jun 2018 |
| IVYNOZVIN_A_NASAL 0.1%W/V DROPS DROPS | 🇲🇼Malawi | — | expired | Jun 2018 |
| XYLOMETAZOLINE
HCL NASAL TOPICAL
METERED DOSE
AEROSOLS | 🇺🇬Uganda | AMMAN PHARMACEUTICA L INDUSTRIES | active | — |
| XYLOMETAZOLINE
HCL NASAL TOPICAL
METERED DOSE
AEROSOLS | 🇺🇬Uganda | AMMAN PHARMACEUTICA L INDUSTRIES | active | — |
XYLOMETAZOLINE HCL in Africa — Regulatory Overview
XYLOMETAZOLINE HCL is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Uganda, Kenya, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 4 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.